The highly anticipated fourth edition of the must-have ECG interpretation resource is now available. The Complete Guide to ECGs has been developed as a unique and practical means for physicians, physicians-in-training, and other medical professionals to improve their ECG interpretation skills. The highly interactive format and comprehensive scope of information are also ideally suited for physicians preparing for the American Board of Internal Medicine (ABIM) Cardiovascular Disease or Internal Medicine Board Exams, the American College of Cardiology ECG proficiency test, and other exams requiring ECG interpretation.
Schizophrenia and its related conditions are all too common among young adults and are prevalent in about 1% of the general population. This is a devastating disorder of thinking; if gone undetected and thus untreated it can lead to robbing an individual of his or her life's goals and aspirations as it develops. If unchecked, it can lead to either suicidal or violent behavior towards others because the affected individual may become plagued by increasing paranoia, bothersome auditory hallucinations commanding various actions, and a general withdrawal from reality. Lately some unfortunate cases of developing schizophrenia have made the news because of the tragic and deadly events they initiated. These have spurred controversial gun control debates and have brought mental illness to the forefront of these debates about government legislation nationally.
The Tarascon Pharmacopoeia 2015 Editions continue the tradition as the leading pocket drug reference packed with vital drug information to help clinicians make better decisions at the point of care.
Topics: pharma, physicians, medicine, mobile medicine, oncology, Pharmacopoeia, prescribing, Tarascon, primary care, doctors, dosing, General Medicine, Pharma, Prescribing, Pyschiatry & Mental Health, Cardiology, Global Health Blog, Hospital Medicine Blog, emergency medicine, hospital medicine, Infectious Disease, infectious disease, prescribe
We are pleased to announce that the Tarascon Pocket Pharmacopoeia 2014 Disease Edition, the newest pocketbook in our acclaimed series of of Pharmacopoeia drug guides, has just published!
Topics: medicine, Pharmacopoeia, prescribing, Tarascon, primary care, Disease, General Medicine, Prescribing, tarascon pocket pharmacopoeia 2014 disease edition, Hospital Medicine Blog, Infectious Disease, primary care
Patients taking drugs known as ACE inhibitors, used to treat high blood pressure, showed slower rates of cognitive decline caused by certain types of dementia, according to a study published by BMJ Open.
The researchers analyzed 361 patients, with an average age of 77, who had been diagnosed with either Alzheimer's disease, vascular dementia, or a mixture of both. Of these patients, 85 were already taking ACE inhibitors; the rest were not.
Each of the patient's cognitive decline was assessed using one of two standardized mental state examinations on two separate occasions, six months apart. The researchers also analyzed the impact of ACE inhibitors on the brain power of 30 patients newly prescribed these drugs, during their first six months of treatment.
Compared with those not taking ACE inhibitors, those on these drugs experienced marginally slower rates of cognitive decline - researchers found a small, but significant, difference in patients who undertook the more sensitivities of the two tests. The study also revealed that the brain power actually improved for 30 new prescribed patients during their first six months of treatment.
This authors suggest that this may be because newly prescribed patients stuck to their medication regimen better, or a by-product of better blood pressure control, or improved blood flow to the brain. But it is the first time that there has been any evidence to suggest that blood pressure lowering drugs may not only halt cognitive decline, but may actually improve brain power.
Great news– Doody’s Review Service recently awarded 5 stars to the Tarascon Clinical Review Series: Internal Medicine by Joseph S. Esherick, MD, FAAFP.
Jones & Bartlett is pleased to announce the launch of the Jones & Bartlett Learning Author’s Corner, a resource for prospective and new authors. The site contains the most up-to-date, general information on art development, manuscript submission, the publishing process, and editorial contacts. It also houses pertinent documents including: author information forms, marketing questionnaires, and proposal guidelines.
Topics: allied health, education, health, Author, Contest, Jones & Bartlett, medicine, oncology, patient education, primary care, General Medicine, Authors, Prescribing, publication, Pyschiatry & Mental Health, Cardiology, Global Health Blog, Hospital Medicine Blog, Infectious Disease, text
April marks the annual observance of National Autism Awareness Month.
Autism is a complex developmental disability that typically appears during the first three years of life and affects a person’s ability to communicate and interact with others. Autism is defined by a certain set of behaviors and is a "spectrum disorder" that affects individuals differently and to varying degrees. There is no known single cause of autism, but increased awareness and funding can help families today.
In March 2012, the Centers for Disease Control and Prevention issued their ADDM autism prevalence report. The report concluded that the prevalence of autism had risen to 1 in every 88 births in the United States and almost 1 in 54 boys. The spotlight shown on autism as a result of the prevalence increase opens opportunities for the nation to consider how to serve these families facing a lifetime of supports for their children.